These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1810689)

  • 21. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
    Osadchii OE
    Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Registration of monophasic action potential of the right atrium and ventricle in man].
    Gavrilesco S; Cotoi S; Pop T
    Rev Roum Med Intern; 1972; 9(1):23-32. PubMed ID: 5052334
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of ventricular arrhythmias.
    Fogoros RN
    Am Fam Physician; 1986 Mar; 33(3):236-46. PubMed ID: 3953344
    [No Abstract]   [Full Text] [Related]  

  • 24. β
    Zhao YH; Huang HX; Liu P; Du YH; Wang P; Wang W; Wu Y; Wang L; Ma CS; Liu HR
    Exp Physiol; 2017 Jan; 102(1):25-33. PubMed ID: 27862484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multistable spatiotemporal patterns of cardiac activity.
    Glass L
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10409-10. PubMed ID: 16027355
    [No Abstract]   [Full Text] [Related]  

  • 26. The monophasic action potential of the right atrium.
    Gavrilescu S; Cotoi S; Pop T
    Cardiology; 1972; 57(4):200-7. PubMed ID: 5074756
    [No Abstract]   [Full Text] [Related]  

  • 27. Arrhythmias and antiarrhythmic drugs.
    Hoffman BF
    Mt Sinai J Med; 1997 Mar; 64(2):136-41. PubMed ID: 9057472
    [No Abstract]   [Full Text] [Related]  

  • 28. hERG 1b is critical for human cardiac repolarization.
    Jones DK; Liu F; Vaidyanathan R; Eckhardt LL; Trudeau MC; Robertson GA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18073-7. PubMed ID: 25453103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological and proarrhythmic parameters in transmural canine left-ventricular needle biopsies.
    Verduyn SC; Jungschleger JG; Stengl M; Spätjens RL; Beekman JD; Vos MA
    Pflugers Arch; 2004 Oct; 449(1):115-22. PubMed ID: 15258763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Short QT Syndromes].
    Schulze-Bahr E
    Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genetic framework for improving arrhythmia therapy.
    Knollmann BC; Roden DM
    Nature; 2008 Feb; 451(7181):929-36. PubMed ID: 18288182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant correlation between monophasic action potential (MAP) durations and activation-recovery intervals (ARIs) determined at the maximum positive slope of the positive T wave (conventional method).
    Yue AM
    Heart Rhythm; 2007 Jan; 4(1):120-1; author reply 121. PubMed ID: 17199007
    [No Abstract]   [Full Text] [Related]  

  • 33. Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
    Osadchii OE
    Fundam Clin Pharmacol; 2014 Aug; 28(4):382-93. PubMed ID: 23952942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.
    Fabritz L; Kirchhof P; Franz MR; Eckardt L; Mönnig G; Milberg P; Breithardt G; Haverkamp W
    Basic Res Cardiol; 2003 Feb; 98(1):25-32. PubMed ID: 12494266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological basis for antiarrhythmic drug action.
    Wit AL
    Clin Physiol Biochem; 1985; 3(2-3):127-34. PubMed ID: 3891195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
    Bonatti V; Rolli A; Botti G
    Eur Heart J; 1985 Nov; 6 Suppl D():131-43. PubMed ID: 2417848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve.
    Roden DM; Yang T
    Circulation; 2005 Sep; 112(10):1376-8. PubMed ID: 16145010
    [No Abstract]   [Full Text] [Related]  

  • 38. Congenital and acquired long QT syndromes.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Wang J; Hegele RA; Yee R
    Can J Cardiol; 2003 Jan; 19(1):76-87. PubMed ID: 12571698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of life-threatening arrhythmias--still an unresolved problem.
    Haugaa KH; Edvardsen T; Amlie JP
    Cardiology; 2011; 118(2):129-37. PubMed ID: 21555886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.